中华放射学杂志
中華放射學雜誌
중화방사학잡지
Chinese Journal of Radiology
2010年
3期
303-307
,共5页
卢再鸣%梁宏元%孙巍%温锋%毛晓楠%郭启勇
盧再鳴%樑宏元%孫巍%溫鋒%毛曉楠%郭啟勇
로재명%량굉원%손외%온봉%모효남%곽계용
肝肿瘤%胆管肿瘤%肿瘤循环细胞%放射学,介入性
肝腫瘤%膽管腫瘤%腫瘤循環細胞%放射學,介入性
간종류%담관종류%종류순배세포%방사학,개입성
Liver neoplasms%Bile duct neoplasms%Neoplasms circulating cells%Radiology,interventional
目的 探讨经皮介入治疗肝癌合并胆管癌栓致梗阻性黄疸的方法和临床价值.方法 回顾性分析16例经病理及影像检查证实为肝癌合并胆管癌栓造成梗阻性黄疸的患者资料,16例均行经皮穿刺造影后置管引流术,根据患者置管后的临床表现,分别采用永久性外引流、内引流定期调整引流管以及覆膜支架植入等治疗方法,术后检测血清总胆红素(TBIL)水平,并采用配对t检验与术前对比,根据TBIL下降情况及临床症状缓解情况来评价治疗的有效性,并在2年的随访期限内观察患者生存期.结果 16例穿刺引流均获得成功,其中永久性外引流2例,内引流并定期调管7例,留置覆膜支架7例.16例经皮介入治疗前总胆红素平均为(261.9±77.2)μmol/L,治疗后2周为(161.2±80.5)μmol/L,差异有统计学意义(t=7.366,P<0.01).16例生存时间为30~391 d,平均生存时间204 d,中位生存时间为200 d.穿刺引流的主要并发症为出血和感染,经止血及抗炎等常规治疗可有效控制.结论 对于肝癌合并胆管癌栓所致的梗阻性黄疸,经皮介入治疗技术成功率高,临床疗效较好.
目的 探討經皮介入治療肝癌閤併膽管癌栓緻梗阻性黃疸的方法和臨床價值.方法 迴顧性分析16例經病理及影像檢查證實為肝癌閤併膽管癌栓造成梗阻性黃疸的患者資料,16例均行經皮穿刺造影後置管引流術,根據患者置管後的臨床錶現,分彆採用永久性外引流、內引流定期調整引流管以及覆膜支架植入等治療方法,術後檢測血清總膽紅素(TBIL)水平,併採用配對t檢驗與術前對比,根據TBIL下降情況及臨床癥狀緩解情況來評價治療的有效性,併在2年的隨訪期限內觀察患者生存期.結果 16例穿刺引流均穫得成功,其中永久性外引流2例,內引流併定期調管7例,留置覆膜支架7例.16例經皮介入治療前總膽紅素平均為(261.9±77.2)μmol/L,治療後2週為(161.2±80.5)μmol/L,差異有統計學意義(t=7.366,P<0.01).16例生存時間為30~391 d,平均生存時間204 d,中位生存時間為200 d.穿刺引流的主要併髮癥為齣血和感染,經止血及抗炎等常規治療可有效控製.結論 對于肝癌閤併膽管癌栓所緻的梗阻性黃疸,經皮介入治療技術成功率高,臨床療效較好.
목적 탐토경피개입치료간암합병담관암전치경조성황달적방법화림상개치.방법 회고성분석16례경병리급영상검사증실위간암합병담관암전조성경조성황달적환자자료,16례균행경피천자조영후치관인류술,근거환자치관후적림상표현,분별채용영구성외인류、내인류정기조정인류관이급복막지가식입등치료방법,술후검측혈청총담홍소(TBIL)수평,병채용배대t검험여술전대비,근거TBIL하강정황급림상증상완해정황래평개치료적유효성,병재2년적수방기한내관찰환자생존기.결과 16례천자인류균획득성공,기중영구성외인류2례,내인류병정기조관7례,류치복막지가7례.16례경피개입치료전총담홍소평균위(261.9±77.2)μmol/L,치료후2주위(161.2±80.5)μmol/L,차이유통계학의의(t=7.366,P<0.01).16례생존시간위30~391 d,평균생존시간204 d,중위생존시간위200 d.천자인류적주요병발증위출혈화감염,경지혈급항염등상규치료가유효공제.결론 대우간암합병담관암전소치적경조성황달,경피개입치료기술성공솔고,림상료효교호.
Objective To explore the method and value of percutanously interventional therapeusis for treatment of obstructive jaundice caused by hepatocellular carcinoma accompanied with bile duct thrombosis.Methods Sixteen cases with bile duct thrombosis proved by pathology and imaging examinations were retrospectively analyzed.According to the clinical symptoms, all the patients received percutaneous transhepatic biliary drainage (PTBD) including permanent external drainage, temporary internal drainage and implantation of covered stents.Serum total bilirubin (TBIL) after the interventional therapeusis were measured and compared with that before the treatments by t test to evaluate the efficacy of these treatments.The relief of clinical symptoms was also reviewed to evaluate the efficacy of these treatments.The patients were followed up within 2 years.Results The PTBD was successfully performed in 16 cases.Permanent external drainage, temporary internal drainage and implantation of covered stents were performed in 2 patients, 7 patients and 7 patients respectively.TBIL after the interventional therapy decreased significantly (t=7.366, P<0.01) to (161.2±80.5) μmol/L averagely from (261.9±77.2)μmol/L before the treatments.All the patients died before the end of followed-up.The average survival time was 204 days (30 to 391 d)and the median survival time was 200 days.Bleeding and infection were the main complications, which could be controlled successfully by routine treatments.Conclusion With high achievement ratio and good efficacy, percutanously interventional therapeusis are good choices for the treatments of obstructive jaundice due to bile duct thrombosis.